Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4?717?839 people.
Por:
Solmi M, Firth J, Miola A, Fornaro M, Frison E, Fusar-Poli P, Dragioti E, Shin JI, Carvalho AF, Stubbs B, Koyanagi A, Kisely S and Correll CU
Publicada:
1 ene 2020
Ahead of Print:
28 nov 2019
Resumen:
Since people with mental illness are more likely to die from cancer, we assessed whether people with mental illness undergo less cancer screening compared with the general population.
Filiaciones:
Solmi M:
Neurosciences Department, University of Padua, Padua, Italy
Neuroscience Center, University of Padua, Padua, Italy
Early Psychosis: Interventions and Clinical-detection Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Firth J:
NICM Health Research Institute, Western Sydney University, Sydney, NSW Australia
Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Miola A:
Neurosciences Department, University of Padua, Padua, Italy
Fornaro M:
Centre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia
Frison E:
Medicine and Surgery School, University of Padua, Padua, Italy
Department of Neuroscience, Reproductive Sciences and Dentistry, Federico II University, Naples, Italy
Fusar-Poli P:
Early Psychosis: Interventions and Clinical-detection Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
OASIS service, South London and Maudsley NHS Foundation Trust, London, UK
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
National Institute for Health Research, Maudsley Biomedical Research Centre, London, UK
Dragioti E:
Pain and Rehabilitation Center, Department of Medicine and Health Sciences, Linköping University, Linköping, Sweden
Shin JI:
Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea
Carvalho AF:
Department of Psychiatry, University of Toronto, Toronto, ON, Canada
Centre for Addiction and Mental Health, Toronto, ON, Canada
Stubbs B:
Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Physiotherapy Department, South London and Maudsley NHS Foundation Trust, London, UK
Koyanagi A:
Research and Development Unit, Parc Sanitari Sant Joan de Déu, Universitat de Barcelona, Fundació Sant Joan de Déu, CIBERSAM, Dr Antoni Pujadas, Barcelona, Spain
ICREA, Pg Lluís Companys 23, Barcelona, Spain
Kisely S:
School of Medicine, University of Queensland, Brisbane, QLD, Australia
Metro South Addiction and Mental Health Service, Brisbane, Metro South Health, QLD, Australia
Departments of Psychiatry and Community Health and Epidemiology, Dalhousie University, Halifax, NS, Canada
Correll CU:
Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, NY, USA
Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA
Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY, USA
Department of Child and Adolescent Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany
|